Bericht
The right to health in pharmaceutical patent disputes
This paper examines how the courts in three developing countries (Kenya, South Africa, and India) have addressed the tension between patent rights on pharmaceutical products and the right to health. The paper begins by examining the nature of the relationship between patent rights and the right to health. It thereafter explores the justiciability of the right to health in Kenya, South Africa, and India. Furthermore, the paper provides an analysis of how the courts in these three developing countries have adjudicated some of the pharmaceutical patent cases involving tensions between the right to health and patent rights. The paper contends that by incorporating the right to health into the adjudication of patent disputes, courts in developing countries can play a crucial role in improving access to medicines at affordable prices.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Paper ; No. 145
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Subject
-
Gesundheitsversorgung
Grundrecht
Arzneimittel
Patent
Patentrecht
Kenia
Südafrika
Indien
- Event
-
Geistige Schöpfung
- (who)
-
Kolawole Oke, Emmanuel
- Event
-
Veröffentlichung
- (who)
-
South Centre
- (where)
-
Geneva
- (when)
-
2022
- Handle
- Last update
-
10.03.2025, 11:43 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Bericht
Associated
- Kolawole Oke, Emmanuel
- South Centre
Time of origin
- 2022
Other Objects (12)
Pharmaceutical innovation, incremental patenting and compulsory licensing
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
A review of WTO disputes on TRIPS: Implications for use of flexibilities for public health
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Is the right to use trademarks mandated by the TRIPS Agreement?
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Compulsory licensing jurisprudence in South Africa: Do we have our priorities right?
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
The right to health and medicines: The case of recent negotiations on the global strategy on public health, innovation and intellectual property
Pharmaceutical innovation, incremental patenting and compulsory licensing
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
A review of WTO disputes on TRIPS: Implications for use of flexibilities for public health
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Is the right to use trademarks mandated by the TRIPS Agreement?
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Compulsory licensing jurisprudence in South Africa: Do we have our priorities right?
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
The right to health and medicines: The case of recent negotiations on the global strategy on public health, innovation and intellectual property
Pharmaceutical innovation, incremental patenting and compulsory licensing
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
A review of WTO disputes on TRIPS: Implications for use of flexibilities for public health
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Is the right to use trademarks mandated by the TRIPS Agreement?
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Compulsory licensing jurisprudence in South Africa: Do we have our priorities right?
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance